Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema

BMC Pulmonary Medicine

Volumn 11, Issue , 2011, Pages

  Forey, Barbara A ^a   Thornton, Alison J ^b   Lee, Peter N ^a  

^a P N Lee Statistics and Computing Ltd   (United Kingdom)

^b Independent consultant   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT;

ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; ASTHMA; CASE CONTROL STUDY; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CROSS-SECTIONAL STUDY; EMPHYSEMA; FOLLOW UP; FORCED EXPIRATORY VOLUME; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; LUNG FUNCTION; MEDLINE; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; PREVALENCE; PROSPECTIVE STUDY; RESPIRATORY FAILURE; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING; SMOKING CESSATION; SMOKING HABIT; SYSTEMATIC REVIEW; AGE; FEMALE; MALE; REVIEW; RISK FACTOR; SURVIVAL RATE;

AGE FACTORS; BRONCHITIS, CHRONIC; EMPHYSEMA; FEMALE; HUMANS; MALE; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SMOKING; SURVIVAL RATE;

EID: 79958276531     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-11-36     Document Type: Article

References (324)

1. US Surgeon General The health consequences of smoking. Chronic obstructive lung disease. A report of the Surgeon General 1984, Rockville, Maryland: US Department of Health and Human Services; Public Health Service, DHHS (PHS) 84-50205, US Surgeon General., http://www.surgeongeneral.gov/library/reports/index.html
2. Lee PN, Fry JS. Systematic review of the evidence relating FEV1 decline to giving up smoking. BMC Med 2010, 8(84)., http://www.biomedcentral.com/1741-7015/8/84
3. Pauwels R, Buist A, Calverley P, Kenkins C, Hurd S. Global strategy for the diagnosis, management, and prevention of global initiative for chronic obstructive lung disease. NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary. Am J Respir Crit Care Med 2001, 163:1256-1276.
4. Global Initiative for Chronic Obstructive Disease Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2006. Executive summary 2006, Medical Communications Resources, Inc, (Revised 2006), Global Initiative for Chronic Obstructive Disease., http://www.goldcopd.org
5. British Thoracic Society BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997, 52(Suppl 5):1-28. 1758399, 9039230, British Thoracic Society.
6. Siafakas NM, Vermier P, Pride NB, Paoletti P, Gibson J, Howard P, Yernault JC, Decramer M, Higenbottam T, Postma DS, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J 1995, 8:1398-1420. 10.1183/09031936.95.08081398, 7489808.
7. American Thoracic Society Standardization of spirometry: 1987 update. Am Rev Respir Dis 1987, 136:1285-1298. American Thoracic Society.
8. American Thoracic Society Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991, 144:1202-1218. American Thoracic Society.
9. American Thoracic Society Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995, 152:S77-S120. American Thoracic Society.
10. Medical Research Council's Committee on the Aetiology of Chronic Bronchitis Standardized questionaries on respiratory symptoms. Br Med J 1960, 2(5213):1665. 2098467, 13688719, Medical Research Council's Committee on the Aetiology of Chronic Bronchitis.
11. Medical Research Council's Committee on the Aetiology of Chronic Bronchitis Definition and classification of chronic bronchitis for clinical and epidemiological purposes. Lancet 1965, 1:775-779. Medical Research Council's Committee on the Aetiology of Chronic Bronchitis.
12. Gardner MJ, Altman DG. Statistics with confidence. Confidence intervals and statistical guidelines 1989, London: British Medical Journal.
13. Fleiss JL, Gross AJ. Meta-analysis in epidemiology, with special reference to studies of the association between exposure to environmental tobacco smoke and lung cancer: a critique. J Clin Epidemiol 1991, 44:127-139. 10.1016/0895-4356(91)90261-7, 1995774.
14. Hamling J, Lee P, Weitkunat R, Ambühl M. Facilitating meta-analyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease category. Stat Med 2008, 27:954-970. 10.1002/sim.3013, 17676579.
15. Lee PN. Simple methods for checking for possible errors in reported odds ratios, relative risks and confidence intervals. Stat Med 1999, 18:1973-1981. 10.1002/(SICI)1097-0258(19990815)18:15<1973::AID-SIM166>3.0.CO;2-G , 10440880.
16. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634. 2127453, 9310563.
17. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560. 10.1136/bmj.327.7414.557, 192859, 12958120.
18. Prescott E, Bjerg AM, Andersen PK, Lange P, Vestbo J. Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. Eur Respir J 1997, 10:822-827.
19. Langhammer A, Johnsen R, Holmen J, Gulsvik A, Bjermer L. Cigarette smoking gives more respiratory symptoms among women than among men. The Nord-Trøndelag Health Study (HUNT). J Epidemiol Community Health 2000, 54:917-922. 10.1136/jech.54.12.917, 1731608, 11076988.
20. Xu X, Wang L. Gender difference in smoking effects on adult pulmonary function. Eur Respir J 1994, 7:477-483. 10.1183/09031936.94.07030477, 8013605.
21. Camilli AE, Burrows B, Knudson RJ, Lyle SK, Lebowitz MD. Longitudinal changes in forced expiratory volume in one second in adults. Effects of smoking and smoking cessation. Am Rev Respir Dis 1987, 135:794-799.
22. Dockery DW, Speizer FE, Ferris BG, Ware JH, Louis TA, Spiro A. Cumulative and reversible effects of lifetime smoking on simple tests of lung function in adults. Am Rev Respir Dis 1988, 137:286-292.
23. Xu X, Dockery DW, Ware JH, Speizer FE, Ferris BG. Effects of cigarette smoking on rate of loss of pulmonary function in adults: A longitudinal assessment. Am Rev Respir Dis 1992, 146:1345-1348.
24. Forey B, Hamling J, Hamling J, Lee P, . editors International Smoking Statistics. A collection of historical data from 30 economically developed countries 2006, Sutton, UK: P N Lee Statistics & Computing Ltd, Web, editors., http://www.pnlee.co.uk/iss.htm
25. Rodrigues L, Kirkwood BR. Case-control designs in the study of common diseases: updates on the demise of the rare disease assumption and the choice of sampling scheme for controls. Int J Epidemiol 1990, 19:205-213. 10.1093/ije/19.1.205, 2190942.
26. Alderson MR, Lee PN, Wang R. Risks of lung cancer, chronic bronchitis, ischaemic heart disease, and stroke in relation to type of cigarette smoked. J Epidemiol Community Health 1985, 39:286-293. 10.1136/jech.39.4.286, 1052459, 4086957.
27. Alderson MR, Lee PN, Wang R. Risk of lung cancer, chronic bronchitis, ischaemic heart disease, and stroke in relation to type of cigarette smoked, passive smoking and other factors 1986, [Download ALDERS1986]., http://www.pnlee.co.uk/reflist.htm
28. Alessandri C, Basili S, Violi F, Ferroni P, Gazzaniga PP, Cordova C. Hypercoagulability state in patients with chronic obstructive pulmonary disease. Thromb Haemost 1994, 72:343-346.
29. Amigo H, Erazo M, Oyarzun M, Bello S, Peruga A. Tabaquismo y enfermedad pulmonar obstructiva crónica: determinación de fracciones atribuibles (Smoking and chronic obstructive pulmonary disease: attributable risk determination). Rev Med Chil 2006, 134:1275-1282.
30. Anderson DO, Ferris BG, Zickmantel R. The Chilliwack respiratory survey 1963: IV. The effect of tobacco smoking on the prevalence of respiratory disease. CMAJ 1965, 92:1066-1076.
31. Anderson AE, Hernandez JA, Holmes WL, Foraker AG. Pulmonary emphysema: prevalence, severity and anatomical patterns in macrosections, with respect to smoking habits. Arch Environ Health 1966, 12:569-577.
32. Anderson D. Expression of ras (p21) protein in plasma from exposed workers and from patients with lung disease. Int J Hyg Environ Health 2001, 204:55-60. 10.1078/1438-4639-00073, 11725347.
33. Anderson D, Hughes JA, Cebulska-Wasilewska A, Nizankowska E, Graca B. Ras p21 protein levels in human plasma from patients with chronic obstructive pulmonary disease (COPD) compared with lung cancer patients and healthy controls. Mutat Res 1998, 403:229-235.
34. Auerbach O, Hammond EC, Garfinkel L, Benante C. Relation of smoking and age to emphysema. Whole-lung section study. N Engl J Med 1972, 286:853-857. 10.1056/NEJM197204202861601, 5061068.
35. Auerbach O, Garfinkel L, Hammond EC. Relation of smoking and age to findings in lung parenchyma: a microscopic study. Chest 1974, 65:29-35. 10.1378/chest.65.1.29, 4809331.
36. Bang KM, Gergen PJ, Carroll M. Prevalence of chronic bronchitis among US Hispanics from the Hispanic Health and Nutrition Examination Survey Examination Survey, 1982-84. Am J Public Health 1990, 80:1495-1497. 10.2105/AJPH.80.12.1495, 1405132, 2240338.
37. Beck GJ, Doyle CA, Schachter EN. A longitudinal study of respiratory health in a rural community. Am Rev Respir Dis 1982, 125:375-381.
38. Bednarek M, Plywaczewski R, Jonczak L, Zielinski J. There is no relationship between chronic obstructive pulmonary disease and obstructive sleep apnea syndrome: a population study. Respiration 2005, 72:142-149. 10.1159/000084044, 15824523.
39. Best EWR, Walker CB, Baker PM, Delaquis FM, McGregor JT, McKenzie AC. Summary of a Canadian study of smoking and health. CMAJ 1967, 96:1104-1108.
40. Department of National Health and Welfare Canada A Canadian study of smoking and health 1966, Canada: Department of National Health and Welfare, Department of National Health and Welfare Canada.
41. Björnsson E, Plaschke P, Norrman E, Janson C, Lundbäck B, Rosenhall A, Lindholm N, Berglund E, Boman G. Symptoms related to asthma and chronic bronchitis in three areas of Sweden. Eur Respir J 1994, 7:2146-2153. 10.1183/09031936.94.07122146, 7713195.
42. Brøgger J, Steen VM, Eiken HG, Gulsvik A, Bakke P. Genetic association between COPD and polymorphisms in TNF, ADRB2 and EPHX1. Eur Respir J 2006, 27:682-688. 10.1183/09031936.06.00057005, 16585076.
43. Brown RG, McKeown T, Whitfield AG. A note on the association between smoking and disease in men in the seventh decade. Br J Prev Soc Med 1957, 11:162-164. 1058671, 13471907.
44. Cerveri I, Accordini S, Corsico A, Zoia MC, Carrozzi L, Cazzoletti L, Beccaria M, Marinoni A, Viegi G, de Marco R. Chronic cough and phlegm in young adults. Eur Respir J 2003, 22:413-417. 10.1183/09031936.03.00121103, 14516128.
45. Chapman RS, Calafiore DC, Hasselblad V. Prevalence of persistent cough and phlegm in young adults in relation to long-term ambient sulfur oxide exposure. Am Rev Respir Dis 1985, 132:261-267.
46. Chen Z-M, Xu Z, Collins R, Li W-X, Peto R. Early health effects of the emerging tobacco epidemic in China. JAMA 1997, 278:1500-1504. 10.1001/jama.278.18.1500, 9363969.
47. Chen Y, Breithaupt K, Muhajarine N. Occurrence of chronic obstructive pulmonary disease among Canadians and sex-related risk factors. J Clin Epidemiol 2000, 53:755-761. 10.1016/S0895-4356(99)00211-5, 10941954.
48. Chen J. Age at diagnosis of smoking-related disease. Health Rep 2003, 14:9-19.
49. Cheng XS, Li JZ, Zhang ZX, Liu GH, Hua Y, Li Q. (The relationship between smoking and the incidence of COPD). Zhonghua Jie He He Hu Xi Za Zhi 1999, 22:290-292.
50. Clément J, van de Woestijne KP. Rapidly decreasing forced expiratory volume in one second or vital capacity and development of chronic airflow obstruction. Am Rev Respir Dis 1982, 125:553-558.
51. Coates EO, Bower GC, Reinstein N. Chronic respiratory disease in postal employees. Epidemiologic survey of a group employed in one building. JAMA 1965, 191:161-166.
52. Cocci F, Miniati M, Monti S, Cavarra E, Gambelli F, Battolla L, Lucattelli M, Lungarella G. Urinary desmosine excretion is inversely correlated with the extent of emphysema in patients with chronic obstructive pulmonary disease. Int J Biochem Cell Biol 2002, 34:594-604. 10.1016/S1357-2725(02)00015-8, 11943590.
53. College of General Practitioners Chronic bronchitis in Great Britain. Br Med J 1961, 2:973-979. 1970184, 20789254, College of General Practitioners.
54. Reid DD, Anderson DO, Ferris BG, Fletcher CM. An anglo-american comparison of the prevelence of bronchitis. Br Med J 1964, 2:1487-1491. 10.1136/bmj.2.5423.1487, 1817179, 14214183.
55. Dean G, Lee PN, Todd GF, Wicken AJ. Report on a second retrospective mortality study in North-East England-Part I. Factors related to mortality from lung cancer, bronchitis, heart disease and stroke in Cleveland County, with particular emphasis on the relative risks associated with smoking filter and plain cigarettes 1977, London: Tobacco Research Council, Research Paper 14.
56. Dean G, Lee PN, Todd GF, Wicken AJ. Report on a second retrospective mortality study in North-East England-Part II. Changes in lung cancer and bronchitis mortality and in other relevant factors occurring in areas of North-East England, 1963-72 1978, London: Tobacco Research Council.
57. Dean G, Lee PN, Todd GF, Wicken AJ, Sparks DN. Factors related to respiratory and cardiovascular symptoms in the United Kingdom. J Epidemiol Community Health 1978, 32:86-96. 10.1136/jech.32.2.86, 1060924, 681591.
58. Deane M, Goldsmith JR, Tuma D. Respiratory conditions in outside workers: report on outside plant telephone workers in San Francisco and Los Angeles. Arch Environ Health 1965, 10:323-331.
59. DeJong SR, Veltman RH. The effectiveness of a CNS-led community-based COPD screening and intervention program. Clin Nurse Spec 2004, 18:72-79. 10.1097/00002800-200403000-00012, 15164668.
60. de Marco R, Accordini S, Cerveri I, Corsico A, Sunyer J, Neukirch F, Künzli N, Leynaert B, Janson C, Gislason T, et al. An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages. Thorax 2004, 59:120-125. 10.1136/thorax.2003.011163, 1746950, 14760151.
61. Cerveri I, Accordini S, Verlato G, Corsico A, Zoia MC, Casali L, Burney P, de Marco R. Variations in the prevalence across countries of chronic bronchitis and smoking habits in young adults. Eur Respir J 2001, 18:85-92. 10.1183/09031936.01.00087101, 11510810.
62. Zock J-P, Sunyer J, Kogevinas M, Kromhout H, Burney P, Antó JM. Occupation, chronic bronchitis, and lung function in young adults. An international study. Am J Respir Crit Care Med 2001, 163:1572-1577.
63. de Torres JP, Campo A, Casanova C, Aguirre-Jaime A, Zulueta J. Gender and chronic obstructive pulmonary disease in high-risk smokers. Respiration 2006, 73:306-310. 10.1159/000090051, 16330871.
64. Dickinson JA, Meaker M, Searle M, Ratcliffe G. Screening older patients for obstructive airways disease in a semi-rural practice. Thorax 1999, 54:501-505. 10.1136/thx.54.6.501, 1745503, 10335003.
65. Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ 1994, 309:901-911. 2541142, 7755693.
66. Doll R, Hill AB. Mortality in relation to smoking: ten years' observations of British doctors. Br Med J 1964, 1:1399-1410. 10.1136/bmj.1.5395.1399, 1814562, 14135164.
67. Doll R, Peto R. Mortality in relation to smoking: 20 years' observations on male British doctors. Br Med J 1976, 2:1525-1536. Erratum Br Med J 1980;971, 10.1136/bmj.2.6051.1525, 1690096, 1009386.
68. Doll R, Gray R, Hafner B, Peto R. Mortality in relation to smoking: 22 years' observations on female British doctors. Br Med J 1980, i:967-971.
69. Dontas AS, Jacobs DR, Corcondilas A, Keys A, Hannan P. Longitudinal versus cross-sectional vital capacity changes and affecting factors. J Gerontol 1984, 39:430-438.
70. DoPico GA, Reddan W, Tsiatis A, Peters ME, Rankin J. Epidemiologic study of clinical and physiologic parameters in grain handlers of northern United States. Am Rev Respir Dis 1984, 130:759-765.
71. Ehrlich RI, White N, Norman R, Laubscher R, Steyn K, Lombard C, Bradshaw D. Predictors of chronic bronchitis in South African adults. Int J Tuberc Lung Dis 2004, 8:369-376.
72. Ekberg-Aronsson M, Pehrsson K, Nilsson J, Nilsson PM, Löfdahl CG. Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis. Respir Res 2005, 6:98. 10.1186/1465-9921-6-98, 1224873, 16120227.
73. Enright PL, Kronmal RA, Higgins MW, Schenker MB, Haponik EF. Prevalence and correlates of respiratory symptoms and disease in the elderly. Chest 1994, 106:827-834. 10.1378/chest.106.3.827, 8082366.
74. Enstrom JE, Kabat GC. Environmental tobacco smoke and tobacco related mortality in a prospective study of Californians, 1960-98. BMJ 2003, 326:1057-1061. 10.1136/bmj.326.7398.1057, 155687, 12750205.
75. Ferris BG, Higgins ITT, Higgins MW, Peters JM, Van Ganse WF, Goldman MD. Chronic nonspecific respiratory disease, Berlin, New Hampshire, 1961-1967: A cross-sectional study. Am Rev Respir Dis 1971, 104:232-244.
76. Anderson DO, Ferris BGJ. Role of tobacco smoking in the causation of chronic respiratory disease. N Engl J Med 1962, 267:787-794. 10.1056/NEJM196210182671601, 14012834.
77. Ferris BJ, Anderson DO. The prevalence of chronic respiratory disease in a New Hampshire town. Am Rev Respir Dis 1962, 864:165-177.
78. Ferris BG, Higgins ITT, Higgins MW, Peters JM. Chronic nonspecific respiratory disease in Berlin, New Hampshire, 1961 to 1967. Am Rev Respir Dis 1973, 107:110-122.
79. Ferris BG, Chen H, Puleo S, Murphy RLH. Chronic nonspecific respiratory disease in Berlin, New Hampshire, 1967 to 1973. A further follow-up study. Am Rev Respir Dis 1976, 113:475-485.
80. Fidan F, Cimrin AH, Ergor G, Sevinc C. Airway disease risk from environmental tobacco smoke among coffeehouse workers in Turkey. Tob Control 2004, 13:161-166. 10.1136/tc.2003.003731, 1747851, 15175534.
81. Finklea JF, Goldberg J, Hasselblad V, Shy CM, Hayes CG. Prevalence of chronic respiratory disase symptoms in military recruits: Chicago induction center, 1969. Health consequences of sulfur oxides: A report from CHESS, 1970-1971 1974, North Carolina: US Environmental Protection Agency, 4-23-4-36., http://www.epa.gov/nscep/
82. Fletcher CM, Elmes PC, Fairbairn AS, Wood CH. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J 1959, 2:257-266. Erratum Br Med J 1959;2(5153):708, 10.1136/bmj.2.5147.257, 1990153, 13823475.
83. Forastiere F, Balmes J, Scarinci M, Tager IB. Occupation, asthma, and chronic repiratory symptoms in a community sample of older women. Am J Respir Crit Care Med 1998, 157:1864-1870.
84. Foxman B, Sloss EM, Lohr KN, Brook RH. Chronic bronchitis: prevalence, smoking habits, impact, and antismoking advice. Prev Med 1986, 15:624-631. 10.1016/0091-7435(86)90067-8, 3797394.
85. Fukuchi Y, Nishimura M, Ichinose M, Adachi M, Nagai A, Kuriyama T, Takahashi K, Nishimura K, Ishioka S, Aizawa H, et al. COPD in Japan: the Nippon COPD Epidemiology study. Respirology 2004, 9:458-465. 10.1111/j.1440-1843.2004.00637.x, 15612956.
86. Geijer RMM, Sachs APE, Verheij TJM, Salomé PL, Lammers J-WJ, Hoes AW. Incidence and determinants of moderate COPD (GOLD II) in male smokers aged 40-65 years: 5-year follow up. Br J Gen Pract 2006, 56:656-661. 1876630, 16953996.
87. Godtfredsen NS, Vestbo J, Osler M, Prescott E. Risk of hospital admission for COPD following smoking cessation and reduction: a Danish population study. Thorax 2002, 57:967-972. 10.1136/thorax.57.11.967, 1746230, 12403880.
88. Goldberg HE, Finklea JF, Nelson CJ, Steen WB, Chapman RS, Swanson DH, Cohen AA. Prevalence of chronic respiratory disease symptoms in adults: 1970 survey of New York communities. Health consequences of sulfur oxides: A report from CHESS, 1970-1971 1974, North Carolina: US Environmental Protection Agency, 5-33-5-47., http://www.epa.gov/nscep/
89. Gulsvik A. Prevalence and manifestations of obstructive lung disease in the city of Oslo. Scand J Respir Dis 1979, 60:286-296.
90. Gulsvik A. Obstructive lung disease in an urban population. Methodological aspects and prevalence estimates of a cross-sectional survey, and some possible risk factors in Oslo, Norway 1979, Norway: University of Oslo.
91. Gulsvik A. Prevalence of respiratory symptoms in the city of Oslo. Scand J Respir Dis 1979, 60:275-285.
92. Haenszel W, Hougen A. Prevalence of respiratory symptoms in Norway. J Chronic Dis 1972, 25:519-544. 10.1016/0021-9681(72)90151-8, 4647215.
93. Hammond EC. Smoking in relation to the death rates of one million men and women. Epidemiological approaches to the study of cancer and other chronic diseases 1966, 127-204. Bethesda, Maryland: U.S. Department of Health, Education, and Welfare. Public Health Service National Cancer Institute, Haenszel W, National Cancer Institute Monograph 19.
94. Hammond EC. Smoking in relation to mortality and morbidity. Findings in first thirty-four months of follow-up in a prospective study started in 1959. J Natl Cancer Inst 1964, 32:1161-1188.
95. Lee PN, Garfinkel L. Mortality and type of cigarette smoked. J Epidemiol Community Health 1981, 35:16-22. 10.1136/jech.35.1.16, 1052113, 7264528.
96. US Surgeon General Reducing the health consequences of smoking. 25 years of progress. A report of the Surgeon General 1989, Rockville, Maryland: US Department of Health and Human Services; Public Health Services, DHHS Publication No. (CDC) 89-8411, US Surgeon General., http://www.surgeongeneral.gov/library/reports/index.html
97. Thun MJ, Day-Lally C, Myers DG, Calle EE, Flanders WD, Zhu BP, Namboodiri MM, Heath CW. Trends in tobacco smoking and mortality from cigarette use in cancer prevention studies I (1959 through 1965) and II (1982 through 1988). Changes in cigarette-related disease risks and their implications for prevention and control 1997, 305-382. Rockville, Maryland: US Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Shopland DR, Burns DM, Garfinkel L, Samet JM, Smoking and Tobacco Control. Monograph No. 8. NIH Pub. No. 97-4213.., http://cancercontrol.cancer.gov/tcrb/monographs/8/m8_4.pdf
98. Hardie JA, Vollmer WM, Buist AS, Bakke P, Morkve O. Respiratory symptoms and obstructive pulmonary disease in a population aged over 70 years. Respir Med 2005, 99:186-195. 10.1016/j.rmed.2004.06.006, 15715185.
99. Harik-Khan RI, Fleg JL, Wise RA. Body mass index and the risk of COPD. Chest 2002, 121:370-376. 10.1378/chest.121.2.370, 11834645.
100. Harris-Eze AOC. Smoking habits and chronic bronchitis in Nigerian soldiers. East Afr Med J 1993, 70:763-767.
101. Hawthorne VM, Fry JS. Smoking and health: the association between smoking behaviour, total mortality, and cardiorespiratory disease in west central Scotland. J Epidemiol Community Health 1978, 32:260-266. 10.1136/jech.32.4.260, 1060966, 744817.
102. Hayes CG, Hammer DI, Shy CM, Hasselblad V, Sharp CR, Creason JP, McClain KE. Prevalence of chronic respiratory disease symptoms in adults: 1970 survey of five Rocky Mountain communities. Health consequences of sulfur oxides: A report from CHESS, 1970-1971 1974, North Carolina: US Environmental Protection Agency, 3-19-3-33., http://www.epa.gov/nscep/
103. Hedman J, Kaprio J, Poussa T, Nieminen MM. Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. Int J Epidemiol 1999, 28:717-722. 10.1093/ije/28.4.717, 10480701.
104. Higgins ITT. Respiratory symptoms, bronchitis, and ventilatory capacity in random sample of an agricultural population. Br Med J 1957, 2:1198-1203. 10.1136/bmj.2.5055.1198, 1962819, 13472086.
105. Higgins ITT, Cochran JB. Respiratory symptoms, bronchitis, and disability in a random sample of an agricultural community in Dumfriesshire. Tubercle 1958, 39:296-301. 10.1016/S0041-3879(58)80092-6, 13592914.
106. Higgins MW, Keller JB. Trends in COPD morbidity and mortality in Tecumseh, Michigan. Am Rev Respir Dis 1989, 140:S42-S48.
107. Higgins MW, Keller JB, Becker M, Howatt W, Landis JR, Rotman H, Weg JG, Higgins I. An index of risk for obstructive airways disease. Am Rev Respir Dis 1982, 125:144-151.
108. Higgins MW, Keller JB, Metzner HL. Smoking, socioeconomic status and chronic respiratory disease. Am Rev Respir Dis 1977, 116:403-410.
109. Metzner HL, Carman WJ, House J. Health practices, risk factors, and chronic disease in Tecumseh. Prev Med 1983, 12:491-507. 10.1016/0091-7435(83)90204-9, 6622434.
110. Hirayama T. Smoking and cancer in Japan. A prospective study on cancer epidemiology based on census population in Japan. Results of 13 years follow up. The UICC Smoking Control Workshop 1982, 2-8. University of Nagoya Press, Tominaga S, Aoki K.
111. Hirayama T. Health effects of active and passive smoking. Smoking and health 1987. Proceedings of the 6th World Conference on Smoking and Health, Tokyo, 9-12 November 1987 1988, 75-86. Amsterdam: Elsevier Science Publishers B.V. (Biomedical Division), Aoki M, Hisamichi S, Tominaga S, International Congress Series No. 780.
112. Ho SC, Zhan SY, Tang JL, Chan SG, Woo J. Smoking and mortality in an older Chinese cohort. J Am Geriatr Soc 1999, 47:1445-1450.
113. Lai CKW, Ho SC, Lau J, Yuen YK, Ho SS, Chan CHS, Woo J. Respiratory symptoms in elderly Chinese living in Hong Kong. Eur Respir J 1995, 8:2055-2061. 10.1183/09031936.95.08122055, 8666100.
114. Holland WW, Stone RW. Respiratory disorders in United States east coast telephone men. Am J Epidemiol 1965, 82:95-101.
115. Hollnagel H, Madsen F, Larsen S. Lungesymptomer, lungefunktionstests, rygevaner og erhvervseksponering blandt 40-årige mænd og kvinder i Glopstrup. II. Indbyrdes relationer (Pulmonary symptoms, pulmonary function tests, smoking habits and occupational exposure among 40-year old men and women in Glostrup. II. Interrelations). Ugeskr Laeger 1983, 145:118-124.
116. Hollnagel H, Madsen F. Lungesymptomer, lungefunktionstests, rygevaner og erhvervseksponering blandt 40-årige mænd og kvinder i Glostrup. I. Fordelinger og relation til sociale forhold (Pulmonary symptoms, pulmonary function tests, smoking habits and occupational exposure among 40-year old men and women in Glostrup. I. Distribution and relation to sociodemographic variables). Ugeskr Laeger 1983, 145:113-118.
117. House DE, Finklea JF, Shy CM, Calafiore DC, Riggan WB, Southwick JW, Olsen LJ. Prevalence of chronic respiratory disease symptoms in adults: 1970 survey of salt lake basin communities. Health consequences of sulfur oxides: A report from CHESS, 1970-1971 1974, North Carolina: US Environmental Protection Agency, 2-41-2-54. EPA-650/1-74-004., http://www.epa.gov/nscep/
118. Hozawa A, Billings JL, Shahar E, Ohira T, Rosamond WD, Folsom AR. Lung function and ischemic stroke incidence: the Atherosclerosis Risk in Communities study. Chest 2006, 130:1642-1649. 10.1378/chest.130.6.1642, 17166977.
119. Shahar E, Folsom AR, Melnick SL, Tockman MS, Comstock GW, Gennaro V, Higgins MW, Sorlie PD, Ko W-J, Szklo M. Dietary n-3 polyunsaturated fatty acids and smoking-related chronic obstructive pulmonary disease. N Engl J Med 1994, 331:228-233. 10.1056/NEJM199407283310403, 8015569.
120. Shahar E, Boland LL, Folsom AR, Tockman MS, McGovern PG, Eckfeldt JH. Docosahexaenoic acid and smoking-related chronic obstructive pulmonary disease. The Atherosclerosis Risk in Communities Study Investigators. Am J Respir Crit Care Med 1999, 159:1780-1785.
121. Hrubec Z, Cederlof R, Friberg L, Horton R, Ozolins G. Respiratory symptoms in twins: effects of residence-associated air pollution, tobacco and alcohol use, and other factors. Arch Environ Health 1973, 27:189-195.
122. Huchon GJ, Vergnenègre A, Neukirch F, Brami G, Roche N, Preux P-M. Chronic bronchitis among French adults: high prevalence and underdiagnosis. Eur Respir J 2002, 20:806-812. 10.1183/09031936.02.00042002, 12412668.
123. Huhti E. Prevalence of respiratory symptoms, chronic bronchitis and pulmonary emphysema in a Finnish rural population. Field survey of age group 40-64 in the Harjavalta area. Acta Tuberc Pneumonol Scand 1965, LXI(Suppl 61):1-111.
124. Huhti E, Ikkala J. A 10-year follow-up study of respiratory symptoms and ventilatory function in a middle-aged rural population. Eur J Respir Dis 1980, 61:33-45.
125. Huhti E, Takala J, Nuutinen J, Poukkula A. Chronic respiratory disease in rural men. An epidemiological survey of Hankasalmi, Finland. Ann Clin Res 1978, 10:87-94.
126. Itabashi S, Fukushima T, Aikawa T, Yanai M, Sekizawa K, Sasaki H, Takishima T. Allergic sensitization in elderly patients with chronic obstructive pulmonary disease. Respiration 1990, 57:384-388. 10.1159/000195876, 2099572.
127. Jacobs DR, Adachi H, Mulder I, Kromhout D, Menotti A, Nissinen A, Blackburn H. Cigarette smoking and mortality risk. Twenty-five-year follow-up of the Seven Countries Study. Arch Intern Med 1999, 159:733-740. 10.1001/archinte.159.7.733, 10218754.
128. Jaén Diaz JI, de Castro Mesa C, Gontán G, Salamanca MJ, López de Castro F. Prevalence of chronic obstructive pulmonary disease and risk factors in smokers and ex-smokers. Arch Bronconeumol 2003, 39:554-558. 10.1157/13054361, 14636492.
129. Jensen EJ, Dahl R, Steffensen F. Bronchial reactivity to cigarette smoke in smokers: repeatability, relationship to methacholine reactivity, smoking and atopy. Eur Respir J 1998, 11:670-676.
130. Jindal SK, Aggarwal AN, Chaudhry K, Chhabra SK, D'Souza GA, Gupta D, Katiyar SK, Kumar R, Shah B, Vijayan VK. A multicentric study on epidemiology of chronic obstructive pulmonary disease and its relationship with tobacco smoking and environmental tobacco smoke exposure. Indian J Chest Dis Allied Sci 2006, 48:23-29.
131. Johannessen A, Omenaas ER, Bakke PS, Gulsvik A. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study. Thorax 2005, 60:842-847. 10.1136/thx.2005.043943, 1747202, 16085729.
132. Bakke PS, Baste V, Hanoa R, Gulsvik A. Prevalence of obstructive lung disease in a general population: relation to occupational title and exposure to some airborne agents. Thorax 1991, 46:863-870. 10.1136/thx.46.12.863, 463489, 1792631.
133. Johannessen A, Omenaas E, Bakke P, Gulsvik A. Incidence of GOLD-defined chronic obstructive pulmonary disease in a general adult population. Int J Tuberc Lung Dis 2005, 9:926-932.
134. Omenaas E, Bakke P, Eide GE, Elsayed S, Gulsvik A. Total serum IgE and FEV1 by respiratory symptoms and obstructive lung disease in adults of a Norwegian community. Clin Exp Allergy 1995, 25:682-689. 10.1111/j.1365-2222.1995.tb00004.x, 7584678.
135. Joshi RC, Madan RN, Brash AA. Prevalence of chronic bronchitis in an industrial population in North India. Thorax 1975, 30:61-67. 10.1136/thx.30.1.61, 470245, 1124530.
136. Jousilahti P, Vartiainen E, Tuomilehto J, Puska P. Symptoms of chronic bronchitis and the risk of coronary disease. Lancet 1996, 348:567-572. 10.1016/S0140-6736(96)02374-4, 8774568.
137. Kachel T. Wpływ naraźenia zawodowego i palenia tytoniu na wyniki badań spirometrycznych oraz objawy przewleklego zapalenia oskrzeli (Effects of occupational exposure and smoking on spirometric tests and symptoms of chronic bronchitis). Pneumonol Alergol Pol 2003, 71:428-439.
138. Kahn HA. The Dorn study of smoking and mortality among U.S. veterans: report on eight and one-half years of observation. Epidemiological approaches to the study of cancer and other chronic diseases 1966, 1-125. Bethesda, Maryland: U.S. Department of Health, Education, and Welfare. Public Health Service National Cancer Institute, Haenszel W, National Cancer Institute Monograph 19.
139. Rogot E, Murray JL. Smoking and causes of death among US Veterans: 16 years of observation. Public Health Rep 1980, 95:213-222. 1422715, 7384406.
140. Rogot E, Hrubec Z. Trends in mortality from chronic obstructive pulmonary disease among U.S. veterans: 1954 to 1979. Am Rev Respir Dis 1989, 140:S69-S75.
141. Hrubec Z, McLaughlin JK. Former cigarette smoking and mortality among U.S. veterans: a 26-year followup, 1954 to 1980. Changes in cigarette-related disease risks and their implications for prevention and control 1997, 501-530. Rockville, Maryland: US Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Shopland DR, Burns DM, Garfinkel L, Samet JM, [Smoking and Tobacco Control. Monograph No. 8] NIH Pub. No. 97-4213., http://cancercontrol.cancer.gov/tcrb/monographs/8/m8_7.pdf
142. Enstrom JE. Smoking cessation and mortality trends among two United States populations. J Clin Epidemiol 1999, 52:813-825.
143. Dorn HF. The mortality of smokers and nonsmokers. Proceedings of the Social Statistics Section 1958, 34-71. Washington DC: American Statistical Association.
144. Dorn HF. Tobacco consumption and mortality from cancer and other diseases. Public Health Rep 1959, 74:581-593. 1929281, 13668008.
145. Karakatsani A, Andreadaki S, Katsouyanni K, Dimitroulis I, Trichopoulos D, Benetou V, Trichopoulou A. Air pollution in relation to manifestations of chronic pulmonary disease: a nested case-control study in Athens, Greece. Eur J Epidemiol 2003, 18:45-53.
146. Katancik JA, Kritchevsky S, Weyant RJ, Corby P, Bretz W, Crapo RO, Jensen R, Waterer G, Rubin SM, Newman AB. Periodontitis and airway obstruction. J Periodontol 2005, 76:2161-2167. 10.1902/jop.2005.76.11-S.2161, 16277589.
147. Kato I, Tominaga S, Suzuki T. Characteristics of past smokers. Int J Epidemiol 1989, 18:345-354. 10.1093/ije/18.2.345, 2788628.
148. Khoury MJ, Beaty TH, Newill CA, Bryant S, Cohen BH. Genetic-environmental interactions in chronic airways obstruction. Int J Epidemiol 1986, 15:65-72. 10.1093/ije/15.1.65, 3485586.
149. Kim DS, Kim YS, Jung K-S, Chang JH, Lim C-M, Lee JH, Uh S-T, Shim JJ, Lew WJ. Prevalence of chronic obstructive pulmonary disease in Korea: a population-based spirometry survey. Am J Respir Crit Care Med 2005, 172:842-847. 10.1164/rccm.200502-259OC, 15976382.
150. Kiraz K, Kart L, Demir R, Oymak S, Gulmez I, Unalacak M, Ozesmi M. Chronic pulmonary disease in rural women exposed to biomass fumes. Clin Invest Med 2003, 26:243-248.
151. Klayton R, Fallat R, Cohen AB. Determinants of chronic obstrucitive pulmonary disease in patients with intermediate levels of alpha1-antitrypsin. Am Rev Respir Dis 1975, 112:71-75.
152. Kojima S, Sakakibara H, Motani S, Hirose K, Mizuno F, Ito M, Hashimoto S. Effects of smoking and age on chronic obstructive pulmonary disease in Japan. J Epidemiol 2005, 15:113-117. 10.2188/jea.15.113, 16141629.
153. Kotaniemi J-T, Latvala J, Lundbäck B, Sovijärvi A, Hassi J, Larsson K. Does living in a cold climate or recreational skiing increase the risk for obstructive respiratory diseases or symptoms?. Int J Circumpolar Health 2003, 62:142-157.
154. Kotaniemi J-T, Sovijärvi A, Lundbäck B. Chronic obstructive pulmonary disease in Finland: prevalence and risk factors. COPD 2005, 2:331-339. 10.1080/15412550500218122, 17146998.
155. Krzyzanowski M, Jedrychowski W, Wysocki M. Factors associated with change in ventilatory function and the development of chronic obstructive pulmonary disease in a 13-year follow-up of the Cracow study. Risk of chronic obstructive pulmonary disease. Am Rev Respir Dis 1986, 134:1011-1019.
156. Kubík A. The influence of smoking and other etiopathogenetic factors on the incidence of bronchogenic carcinoma and chronic nonspecific respiratory diseases. Czech Med 1984, 7:25-34.
157. Kuller LH, Ockene JK, Townsend M, Browner W, Meilahn E, Wentworth DN. The epidemiology of pulmonary function and COPD mortality in the multiple risk factor intervention trial. Am Rev Respir Dis 1989, 140(3 Pt 2):S76-S81.
158. Lai CKW, Ran PX, Ko FWS, Liu SM, Zheng JP, Zhong NS, Ip MSM. COPD: the chinese experience. Eur Respir J 2006, 27:846-849.
159. Lam TH, He Y, Li LS, He SF, Liang BQ. Mortality attributable to cigarette smoking in China. JAMA 1997, 278:1505-1508. 10.1001/jama.278.18.1505, 9363970.
160. Lam TH, He Y, Shi QL, Huang JY, Zhang F, Wan ZH, Sun CS, Li LS. Smoking, quitting, and mortality in a Chinese cohort of retired men. Ann Epidemiol 2002, 12:316-320. 10.1016/S1047-2797(01)00258-7, 12062918.
161. He Y, Taihing L, Shi Q, Huang J, Zhang F, Wan Z, Li L. A prospective study on smoking, quitting and mortality in a cohort of elderly in Xi'an, China. Zhonghua Liu Xing Bing Xue Za Zhi 2002, 23:186-189.
162. Sai X-Y, He Y, Wang B, Meng D-R, Xing Q-J, Xiao D, Wang Y, Yan Y-P. (An 18-year follow up study on the risk factors of deaths regarding chronic obstructive pulmonary disease in Xi'an, China). Zhonghua Liu Xing Bing Xue Za Zhi 2006, 27:765-768.
163. Lambert PM, Reid DD. Smoking, air pollution, and bronchitis in Britain. Lancet 1970, i:853-857.
164. Todd GF, Hunt BM, Lambert PM. Four cardiorespiratory symptoms as predictors of mortality. J Epidemiol Community Health 1978, 32:267-274. 10.1136/jech.32.4.267, 1060967, 744818.
165. Lange P, Nyboe J, Appleyard M, Jensen G, Schnohr P. Relationship of the type of tobacco and inhalation pattern to pulmonary and total mortality. Eur Respir J 1992, 5:1111-1117.
166. Prescott EIB, Lange P, Vestbo J. Kronisk ekspektoration og risiko for død ved kronisk obstruktiv lungesygdom (Chronic expectoration and risk of death in chronic obstructive lung disease). Ugeskr Laeger 1996, 158:6456-6460.
167. Lange P, Nyboe J, Appleyard M, Jensen G, Schnohr P. Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes. Thorax 1990, 45:579-585. 10.1136/thx.45.8.579, 462624, 2402719.
168. Vestbo J, Lange P. Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease?. Am J Respir Crit Care Med 2002, 166:329-332. 10.1164/rccm.2112048, 12153965.
169. Løkke A, Lange P, Scharling H, Fabricius P, Vestbo J. Developing COPD: a 25 year follow up study of the general population. Thorax 2006, 61:935-939. 10.1136/thx.2006.062802, 2121175, 17071833.
170. Lange P, Parner J, Prescott E, Vestbo J. Chronic bronchitis in an elderly population. Age Ageing 2003, 32:636-642. 10.1093/ageing/afg108, 14600005.
171. La Vecchia C, Pagano R, Negri E, Decarli A. Smoking and prevalence of disease in the 1983 Italian National Health survey. Int J Epidemiol 1988, 17:50-55. 10.1093/ije/17.1.50, 3384549.
172. Lebowitz MD. Smoking habits and changes in smoking habits as they relate to chronic conditions and respiratory symptoms. Am J Epidemiol 1977, 105:534-543.
173. Burrows B, Lebowitz MD. Characteristics of chronic bronchitis in a warm, dry region. Am Rev Respir Dis 1975, 112:365-370.
174. Lebowitz MD, Burrows B. Quantitative relationships between cigarette smoking and chronic productive cough. Int J Epidemiol 1977, 6:107-113. 10.1093/ije/6.2.107, 892975.
175. Lebowitz MD. Occupational exposures in relation to symptomatology and lung function in a community population. Environ Res 1977, 14:59-67. 10.1016/0013-9351(77)90066-4, 891505.
176. Lebowitz MD. The relationship of socio-environmental factors to the prevalence of obstructive lung diseases and other chronic conditions. J Chronic Dis 1977, 30:599-611. 10.1016/0021-9681(77)90058-3, 903391.
177. Lebowitz MD. Respiratory symptoms and disease related to alcohol consumption. Am Rev Respir Dis 1981, 123:16-19.
178. Lee PN. Mortality from smoking-associated diseases in Great Britain. A statistical analysis of British data from the U.S.A.-U.K.-Norway migrant study 1979, Sutton, Surrey: P N Lee Statistics and Computing Ltd, [Download LEE1979B]]., http://www.pnlee.co.uk/reflist.htm
179. Liaw K-M, Chen C-J. Mortality attributable to cigarette smoking in Taiwan: a 12-year follow-up study. Tob Control 1998, 7:141-148. 10.1136/tc.7.2.141, 1759691, 9789932.
180. Lindberg A, Eriksson B, Larsson L-G, Rönmark E, Sandström T, Lundbäck B. Seven-year cumulative incidence of COPD in an age-stratified general population sample. Chest 2006, 129:879-885. 10.1378/chest.129.4.879, 16608933.
181. Lindström M, Kotaniemi J, Jönsson E, Lundbäck B. Smoking, respiratory symptoms, and diseases. A comparative study between Northern Sweden and Northern Finland: Report from the FinEsS Study. Chest 2001, 119:852-861. 10.1378/chest.119.3.852, 11243968.
182. Liu B-Q, Peto R, Chen Z-M, Boreham J, Wu Y-P, Li J-Y, Campbell TC, Chen J-S. Emerging tobacco hazards in China: 1. Retrospective proportional mortality study of one million deaths. BMJ 1998, 317:1411-1422. 28719, 9822393.
183. Liu SM, Wang XP, Wang DL, Zhou YM, Lu JC, Zheng JP, Zhong NS, Ran PX. (Epidemiologic analysis of COPD in Guangdong province). Zhonghua Yi Xue Za Zhi 2005, 85:747-752.
184. Wang X, Zhou Y, Zeng X, Liu S, Qiu R, Xie J, Zheng J, Lu J, Zhong N, Ran P. (Study on the prevalence rate of chronic obstructive pulmonary disease in northern part of Guangdong province). Zhonghua Liu Xing Bing Xue Za Zhi 2005, 26:211-213.
185. Lundbäck B, Lindberg A, Lindström M, Rönmark E, Jonsson AC, Jönsson E, Larsson L-G, Andersson S, Sandström T, Larsson K. Not 15 but 50% of smokers develop COPD?-Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2003, 97:115-122. 10.1053/rmed.2003.1446, 12587960.
186. Lindberg A, Bjerg-Bäcklund A, Rönmark E, Larsson L-G, Lundbäck B. Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking. Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2006, 100:264-272. 10.1016/j.rmed.2005.04.029, 15975774.
187. Lundbäck B, Stjernberg N, Nyström L, Lundbäck K, Lindström M, Rosenhall L. An interview study to estimate prevalence of asthma and chronic bronchitis. Eur J Epidemiol 1993, 9:123-133. 10.1007/BF00158781, 8519349.
188. Hedlund U, Järvholm B, Lundbäck B. Respiratory symptoms and obstructive lung diseases in iron ore miners: report from the obstructive lung disease in northern Sweden studies. Eur J Epidemiol 2004, 19:953-958. 10.1007/s10654-004-5194-7, 15575354.
189. Lundback B, Nystrom L, Rosenhall L, Stjernberg N. Obstructive lung disease in northern Sweden: respiratory symptoms assessed in a postal survey. Eur Respir J 1991, 4:257-266.
190. Mador MJ, Deniz O, Aggarwal A, Kufel TJ. Quadriceps fatigability after single muscle exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003, 168:102-108. 10.1164/rccm.200202-080OC, 12689846.
191. Magnusson S, Gislason T. Chronic bronchitis in Icelandic males: prevalence, sleep disturbances and quality of life. Scand J Prim Health Care 1999, 17:100-104. 10.1080/028134399750002728, 10439493.
192. Manfreda J, Cheang M, Warren CPW. Chronic respiratory disorders related to farming and exposure to grain dust in a rural adult community. Am J Ind Med 1989, 15:7-19. 10.1002/ajim.4700150103, 2929610.
193. Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2000, 160:1683-1689. 10.1001/archinte.160.11.1683, 10847262.
194. Coultas DB, Mapel D, Gagnon R, Lydick E. The health impact of undiagnosed airflow obstruction in a national sample of United States adults. Am J Respir Crit Care Med 2001, 164:372-377.
195. Mannino DM, Ford ES, Redd SC. Obstructive and restrictive lung disease and functional limitation: data from the Third National Health and Nutrition Examination. J Intern Med 2003, 254:540-547. 10.1111/j.1365-2796.2003.01211.x, 14641794.
196. Hyman JJ, Reid BC. Cigarette smoking, periodontal disease, and chronic obstructive pulmonary disease. J Periodontol 2004, 75:9-15. 10.1902/jop.2004.75.1.9, 15025211.
197. Moore BA, Augustson EM, Moser RP, Budney AJ. Respiratory effects of marijuana and tobacco use in a U.S. sample. J Gen Intern Med 2004, 20:33-37.
198. Sisson JH, Stoner JA, Romberger DJ, Spurzem JR, Wyatt TA, Owens-Ream J, Mannino DM. Alcohol intake is associated with altered pulmonary function. Alcohol 2005, 36:19-30. 10.1016/j.alcohol.2005.05.002, 1868689, 16440475.
199. Mannino DM, Buist AS, Petty TL, Enright PL, Redd SC. Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax 2003, 58:388-393. 10.1136/thorax.58.5.388, 1746680, 12728157.
200. Bang KM. Prevalence of chronic obstructive pulmonary disease in blacks. J Natl Med Assoc 1993, 85:51-55. 2571721, 8426385.
201. Maranetra KN, Chuaychoo B, Dejsomritrutai W, Chierakul N, Nana A, Lertakyamanee J, Naruman C, Suthamsmai T, Sangkaew S, Sreelum W, et al. The prevalence and incidence of COPD among urban older persons of Bangkok Metropolis. J Med Assoc Thai 2002, 85:1147-1155.
202. Marcus EB, Buist AS, MacLean CJ, Yano K. Twenty-year trends in mortality from chronic obstructive pulmonary disease: the Honolulu heart program. Am J Respir Crit Care Med 1989, 140:S64-S68.
203. Matheson MC, Raven J, Walters EH, Abramson MJ, Ellis JA. Microsomal epoxide hydrolase is not associated with COPD in a community-based sample. Hum Biol 2006, 78:705-717. 10.1353/hub.2007.0015, 17564249.
204. Mellström D, Rundgren T, Jagenburg R, Steen B, Svanborg A. Tobacco smoking, aging and health among the elderly: a longitudinal population study of 70-year-old men and an age cohort comparison. Age Ageing 1982, 11:45-58. 10.1093/ageing/11.1.45, 7072560.
205. Menezes AMB, Victora CG, Rigatto M. Chronic bronchitis and the type of cigarette smoked. Int J Epidemiol 1995, 24:95-99. 10.1093/ije/24.1.95, 7797362.
206. Menezes AMB, Perez-Padilla R, Jardim JRB, Muiño A, Lopez MV, Valdivia G, Montes de Oca M, Talamo C, Hallal PC, Victora CG. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005, 366:1875-1881. 10.1016/S0140-6736(05)67632-5, 16310554.
207. Menezes AMB, Jardim JR, Pérez-Padilla R, Camelier A, Rosa F, Nascimento O, Hallal PC. Prevalence of chronic obstructive pulmonary disease and associated factors: the PLATINO Study in São Paulo, Brazil. Cad Saude Publica 2005, 21:1565-1573. 10.1590/S0102-311X2005000500030, 16158163.
208. Meren M, Jannus-Pruljan L, Loit H-M, Põlluste J, Jönsson E, Kiviloog J, Lundbäck B. Asthma, chronic bronchitis and respiratory symptoms among adults in Estonia according to a postal questionnaire. Respir Med 2001, 95:954-964. 10.1053/rmed.2001.1188, 11778792.
209. Miller A, Thornton JC, Anderson HA, Selikoff IJ. Clinical respiratory abnormalities in Michigan. Prevalence by sex and smoking history in a representative sample of the adult population. Chest 1988, 94:1187-1194. 10.1378/chest.94.6.1187, 3056659.
210. Milne JS, Williamson J. Respiratory symptoms and smoking habits in older people with age and sex differences. Respiration 1972, 29:359-370. 10.1159/000192908, 5073547.
211. Milne JS, Maule MM, Williamson J. Method of sampling in a study of older people with a comparison of respondents and non-respondents. Br J Prev Soc Med 1971, 25:37-41. 478628, 5551232.
212. Möller W, Barth W, Kohlhäufl M, Häussinger K, Stahlhofen W, Heyder J. Human alveolar long-term clearance of ferromagnetic iron oxide microparticles in healthy and diseased subjects. Exp Lung Res 2001, 27:547-568. 10.1080/019021401753181827, 11597117.
213. Montnémery P, Ådelroth E, Heuman K, Johannisson A, Johansson S, Lindholm L-H, Lundbäck B, Löfdahl C-G. Prevalence of obstructive lung diseases and respiratory symptoms in southern Sweden. Respir Med 1998, 92:1337-1345. 10.1016/S0954-6111(98)90139-1, 10197227.
214. Montnémery P, Bengtsson P, Elliot A, Lindholm L-H, Nyberg P, Löfdahl CG. Prevalence of obstructive lung diseases and respiratory symptoms in relation to living environment and socio-economic group. Respir Med 2001, 95:744-752. 10.1053/rmed.2001.1129, 11575896.
215. Montnémery P, Popovic M, Andersson M, Greiff L, Nyberg P, Löfdahl CG, Svensson C, Persson CGA. Influence of heavy traffic, city dwelling and socio-economic status on nasal symptoms assessed in a postal population survey. Respir Med 2003, 97:970-977. 10.1016/S0954-6111(03)00126-4, 12924526.
216. Mueller RE, Keble DL, Plummer J, Walker SH. The prevalence of chronic bronchitic, chronic airway obstruction, and respiratory symptoms in a Colorado city. Am Rev Respir Dis 1971, 103:209-228.
217. Nawa T, Nakagawa T, Kusano S, Nakata H. (Prevalence of emphysematous changes as shown by low-dose spiral CT screening images in 6144 healthy subjects). Nihon Kokyuki Gakkai Zasshi 2002, 40:468-472.
218. Nejjari C, Tessier JF, Letenneur L, Lafont S, Dartigues JF, Salamon R. Determinants of chronic bronchitis prevalence in an elderly sample from south-west of France. Monaldi Arch Chest Dis 1996, 51:373-379.
219. Niepsuj G, Kozielski J, Niepsuj K, Ziora D, Polońska A, Cieślicki J, Rauer R, Dworniczak S, Kami|ski J, Jastrze{ogonek}bski D, et al. Przewlekła obturacyjna choroba płuc u mieszkańców miasta Zabrza (Chronic obstructive pulmonary disease in inhabitants of Zabrze). Wiad Lek 2002, 55(Suppl 1):354-359.
220. Nihlén U, Nyberg P, Montnémery P, Löfdahl C-G. Influence of family history and smoking habits on the incidence of self-reported physician's diagnosis of COPD. Respir Med 2004, 98:263-270. 10.1016/j.rmed.2003.10.006, 15002763.
221. Nihlén U, Montnémery P, Lindholm LH, Löfdahl CG. Detection of chronic obstructive pulmonary disease (COPD) in primary health care: role of spirometry and respiratory symptoms. Scand J Prim Health Care 1999, 17:232-237. 10.1080/028134399750002467, 10674301.
222. Nilsson S, Carstensen JM, Pershagen G. Mortality among male and female smokers in Sweden: a 33 year follow up. J Epidemiol Community Health 2001, 55:825-830. 10.1136/jech.55.11.825, 1763319, 11604439.
223. Cederlöf R, Friberg L, Hrubec Z, Lorich U. The relationship of smoking and some social covariables to mortality and cancer morbidity. A ten year follow-up in a probability sample of 55, 000 Swedish subjects age 18-69 1975, Stockholm: Karolinska Institute, Dept of Environmental Hygiene, Part 1 and Part 2.
224. Carstensen J, Pershagen G, Eklund G. Mortality in relation to cigarette and pipe smoking: 16 years' observation of 25, 000 Swedish men. J Epidemiol Community Health 1987, 41:166-172. 10.1136/jech.41.2.166, 1052604, 3655638.
225. Ogilvie AG, Newell DJ. Chronic bronchitis in Newcastle-upon-Tyne 1957, Edinburgh: E and S Livingstone Limited.
226. Omori H, Nakashima R, Otsuka N, Mishima Y, Tomiguchi S, Narimatsu A, Nonami Y, Mihara S, Koyama W, Marubayashi T, et al. Emphysema detected by lung cancer screening with low-dose spiral CT: prevalence, and correlation with smoking habits and pulmonary function in Japanese male subjects. Respirology 2006, 11:205-210. 10.1111/j.1440-1843.2006.00827.x, 16548907.
227. Oswald NC, Harold JT, Martin WJ. Clinical pattern of chronic bronchitis. Lancet 1953, 265:639-643.
228. Oswald NC, Medvei VC. Chronic bronchitis: the effect of cigarette smoking. Lancet 1955, 2:843-847.
229. Pandey MR. Domestic smoke pollution and chronic bronchitis in a rural community of the Hill Region of Nepal. Thorax 1984, 39:337-339. 10.1136/thx.39.5.337, 459798, 6740536.
230. Pandey MR. Prevalence of chronic bronchitis in a rural community of the Hill Region of Nepal. Thorax 1984, 39:331-336. 10.1136/thx.39.5.331, 459797, 6740535.
231. Peat JK, Woolcock AJ, Cullen K. Decline of lung function and development of chronic airflow limitation: a longitudinal study of non-smokers and smokers in Busselton, Western Australia. Thorax 1990, 45:32-37. 10.1136/thx.45.1.32, 475638, 2321175.
232. Knuiman MW, James AL, Divitini ML, Ryan G, Bartholomew HC, Musk AW. Lung function, respiratory symptoms, and mortality: results from the Busselton Health Study. Ann Epidemiol 1999, 9:297-306. 10.1016/S1047-2797(98)00066-0, 10976856.
233. Pelkonen M, Notkola I-L, Nissinen A, Tukiainen H, Koskela H. Thirty-year cumulative incidence of chronic bronchitis and COPD in relation to 30-year pulmonary function and 40-year mortality: a follow-up in middle-aged rural men. Chest 2006, 130:1129-1137. 10.1378/chest.130.4.1129, 17035447.
234. Pérez-Padilla R, Regalado J, Vedal S, Pare P, Chapela R, Sansores R, Selman M. Exposure to biomass smoke and chronic airway disease in Mexican women. A case-control study. Am J Respir Crit Care Med 1996, 154(3 Pt 1):701-706.
235. Peto R, Speizer FE, Cochrane AL, Moore F, Fletcher CM, Tinker CM, Higgins ITT, Gray RG, Richards SM, Gilliland J, et al. The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation. Am Rev Respir Dis 1983, 128:491-500.
236. Pratt PC, Vollmer TR, Miller JA. Epidemiology of pulmonary lesions in nontextile and cotton textile workers: a retrospective autopsy study. Arch Environ Health 1980, 35:133-138.
237. Price DB, Tinkelman DG, Halbert RJ, Nordyke RJ, Isonaka S, Nonikov D, Juniper EF, Freeman D, Hausen T, Levy ML, et al. Symptom-based questionnaire for identifying COPD in smokers. Respiration 2006, 73:285-295. 10.1159/000090142, 16330875.
238. Tinkelman DG, Price DB, Nordyke RJ, Halbert RJ, Isonaka S, Nonikov D, Juniper EF, Freeman D, Hausen T, Levy ML, et al. Symptom-based questionnaire for differentiating COPD and asthma. Respiration 2006, 73:296-305. 10.1159/000090141, 16330874.
239. Reid DD, Cornfield J, Markush RE, Seigel D, Pedersen E, Haenszel W. Studies of disease among migrants and native populations in Great Britain, Norway, and the United States. III. Prevalence of cardiorespiratory symptoms among migrants and native-born in the United States. Epidemiological approaches to the study of cancer and other chronic diseases 1966, 321-346. Bethesda, Maryland: U.S. Department of Health, Education, and Welfare. Public Health Service National Cancer Institute, Haenszel W, National Cancer Institute Monograph 19.
240. Renwick DS, Connolly MJ. Prevalence and treatment of chronic airways obstruction in adults over the age of 45. Thorax 1996, 51:164-168. 10.1136/thx.51.2.164, 473027, 8711649.
241. Riccioni G, De Benedictis M, Della VR, Di Ilio C, Guagnano MT, D'Orazio N. Prevalence and severity of airway obstruction in an Italian adult population. Monaldi Arch Chest Dis 2005, 63:88-92.
242. Rimington J. Cigarette smokers' chronic bronchitis: inhalers and non-inhalers compared. Br J Dis Chest 1974, 68:161-165.
243. Rimington J. Phlegm and filters. Br Med J 1972, 2:262-264. 10.1136/bmj.2.5808.262, 1788954, 5022013.
244. Ryder RC, Dunnill MS, Anderson JA. A quantitative study of bronchial mucous gland volume, emphysema and smoking in a necropsy population. J Pathol 1971, 104:59-71. 10.1002/path.1711040108, 5568351.
245. Sargeant LA, Jaeckel A, Wareham NJ. Interaction of vitamin C with the relation between smoking and obstructive airways disease in EPIC Norfolk. Eur Respir J 2000, 16:397-403. 10.1034/j.1399-3003.2000.016003397.x, 11028650.
246. Patel BD, Luben RN, Welch AA, Bingham SA, Khaw K-T, Day NE, Lomas DA, Wareham NJ. Childhood smoking is an independent risk factor for obstructive airways disease in women. Thorax 2004, 59:682-686. 10.1136/thx.2003.010215, 1747099, 15282389.
247. Sawicki F. Chronic bronchitis and asthmatic disease in Cracow. Uses of epidemiology in planning health services. Proceedings of the Sixth International Scientific Meeting of IEA. Savremena Administracija, Belgrade 1973, 652-662. Davies AM.
248. Sawicki F. Chronic nonspecific respiratory diseases in Cracow. Epidemiological Review 1972, 26:229-250.
249. Schwartz J, Weiss ST. Dietary factors and their relation to respiratory symptoms. The second national health and nutrition examination survey. Am J Epidemiol 1990, 132:67-76.
250. Turkeltaub PC, Gergen PJ. Prevalence of upper and lower respiratory conditions in the US population by social and environmental factors: data from the second National Health and Nutritional Examination Survey, 1976-80 (NHANES II). Ann Allergy 1991, 67:147-154.
251. Shahab L, Jarvis MJ, Britton J, West R. Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax 2006, 61:1043-1047. 10.1136/thx.2006.064410, 2117062, 17040932.
252. Sharp JT, Paul O, Lepper MH, McKean H, Saxton GA. Prevalence of chronic bronchitis in an American male urban industrial population. Am Rev Respir Dis 1965, 91:510-520.
253. Sharp JT, Paul O, McKean H, Best WR. A longitudinal study of bronchitic symptoms and spirometry in a middle-aged, male, industrial population. Am Rev Respir Dis 1973, 108:1066-1077.
254. Shimura S, Andoh Y, Haraguchi M, Shirato K. Continuity of airway goblet cells and intraluminal mucus in the airways of patients with bronchial asthma. Eur Respir J 1996, 9:1395-1401. 10.1183/09031936.96.09071395, 8836649.
255. Shin C, In KH, Shim JJ, Yoo SH, Kang KH, Hong M, Choi K. Prevalence and correlates of airway obstruction in a community-based sample of adults. Chest 2003, 123:1924-1931. 10.1378/chest.123.6.1924, 12796169.
256. Sichletidis L, Tsiotsios I, Gavriilidis A, Chloros D, Kottakis I, Daskalopoulou E, Konstantinidis T. Prevalence of chronic obstructive pulmonary disease and rhinitis in northern Greece. Respiration 2005, 72:270-277. 10.1159/000085368, 15942296.
257. Silva GE, Sherrill DL, Guerra S, Barbee RA. Asthma as a risk factor for COPD in a longitudinal study. Chest 2004, 126:59-65. 10.1378/chest.126.1.59, 15249443.
258. Lebowitz MD, Postma DS, Burrows B. Adverse effects of eosinophilia and smoking on the natural history of newly diagnosed chronic bronchitis. Chest 1995, 108:55-61. 10.1378/chest.108.1.55, 7606992.
259. Postma DS, Lebowitz MD. Persistence and new onset of asthma and chronic bronchitis evaluated longitudinally in a community population sample of adults. Arch Intern Med 1995, 155:1393-1399. 10.1001/archinte.155.13.1393, 7794088.
260. Dodge R, Cline MG, Burrows B. Comparisons of asthma, emphysema, and chronic bronchitis diagnoses in a general population sample. Am Rev Respir Dis 1986, 133:981-986.
261. Sobradillo V, Miravitlles M, Jiménez CA, Gabriel R, Viejo JL, Masa JF, Fernández-Fau L, Villasante C. Estudio IBERPOC en España: prevalencia de síntomas respiratorios habituales y de limitación crónica al flujo aéreo (Epidemiological study of chronic obstructive pulmonary disease in Spain (IBERPOC): prevalence of chronic respiratory symptoms and airflow limitation). Arch Bronconeumol 1999, 35:159-166.
262. Sobradillo Peña VS, Miravitlles M, Gabriel R, Jiménez-Ruiz CA, Villasante C, Masa JF, Viejo JL, Fernández-Fau L. Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest 2000, 118:981-989. 10.1378/chest.118.4.981, 11035667.
263. Jiménez-Ruiz CA, Sobradillo V, Gabriel R, Viejo JL, Masa JF, Miravitlles M, Villasante C, Fernández-Fau L. Síntomas respiratorios y diagnóstico de EPOC en fumadores de distintas labores de tabaco. Resultados del estudio IBERPOC (Respiratory symptoms and diagnosis of COPD in smokers of various types to tobacco. Results from the IBERPOC study). Arch Bronconeumol 2002, 38:530-535.
264. Jiménez-Ruiz C, Miravitlles M, Sobradillo V, Gabriel R, Viejo JL, Masa JF, Fernández-Fau L, Villasante C. Can cumulative tobacco consumption, FTND score, and carbon monoxide concentration in expired air be predictors of chronic obstructive pulmonary disease?. Nicotine Tob Res 2004, 6:649-653. 10.1080/14622200410001727948, 15370161.
265. Speizer FE, Fay ME, Dockery DW, Ferris BG. Chronic obstructive pulmonary disease mortality in six US cities. Am J Respir Crit Care Med 1989, 140:S49-S55.
266. Sterling TD, Rosenbaum WL, Weinkam JJ. Risk attribution and tobacco-related deaths. Am J Epidemiol 1993, 138:128-139.
267. Weinkam JJ, Rosenbaum WL, Sterling TD. Computation of relative risk based on simultaneous surveys: an alternative to cohort and case-control studies. Am J Epidemiol 1992, 136:722-729.
268. Stjernberg N, Eklund A, Nyström L, Rosenhall L, Emmelin A, Strömqvist LH. Prevalence of bronchial asthma and chronic bronchitis in a community in northern Sweden; relation to environmental and occupational exposure to sulphur dioxide. Eur J Respir Dis 1985, 67:41-49.
269. Ström K, Janzon L, Mattisson I, Rosberg H-E, Arborelius M. Asthma but not smoking-related airflow limitation is associated with a high fat diet in men: results from the population study "Men born in 1914", Malmö, Sweden. Monaldi Arch Chest Dis 1996, 51:16-21.
270. Suadicani P, Hein HO, Meyer HW, Gyntelberg F. Exposure to cold and draught, alcohol consumption, and the NS-phenotype are associated with chronic bronchitis: an epidemiological investigation of 3387 men aged 53-75 years: the Copenhagen Male Study. Occup Environ Med 2001, 58:160-164. 10.1136/oem.58.3.160, 1740108, 11171928.
271. Sutinen S, Vaajalahti P, Pääkkö P. Prevalence, severity, and types of pulmonary emphysema in a population of deaths in a Finnish city. Correlation with age, sex and smoking. Scand J Respir Dis 1978, 59:101-115.
272. Tager I, Tishler PV, Rosner B, Speizer FE, Litt M. Studies of the familial aggregation of chronic bronchitis and obstructive airways disease. Int J Epidemiol 1978, 7:55-62. 10.1093/ije/7.1.55, 659050.
273. Tager IB, Speizer FE. Risk estimates for chronic bronchitis in smokers: study of male-female differences. Am Rev Respir Dis 1976, 113:619-625.
274. Tang J-L, Morris JK, Wald NJ, Hole D, Shipley M, Tunstall-Pedoe H. Mortality in relation to tar yield of cigarettes: a prospective study of four cohorts. BMJ 1995, 311:1530-1533. 2548184, 8520394.
275. Henley SJ, Thun MJ, Chao A, Calle EE. Association between exclusive pipe smoking and mortality from cancer and other diseases. J Natl Cancer Inst 2004, 96:853-861. 10.1093/jnci/djh144, 15173269.
276. Taylor DH, Hasselblad V, Henley SJ, Thun MJ, Sloan FA. Benefits of smoking cessation of longevity. Am J Public Health 2002, 92:990-996. 10.2105/AJPH.92.6.990, 1447499, 12036794.
277. Troisi RJ, Speizer FE, Rosner B, Trichopoulos D, Willett WC. Cigarette smoking and incidence of chronic bronchitis and asthma in women. Chest 1995, 108:1557-1561. 10.1378/chest.108.6.1557, 7497760.
278. Trupin L, Earnest G, San Pedro M, Balmes JR, Eisner MD, Yelin E, Katz PP, Blanc PD. The occupational burden of chronic obstructive pulmonary disease. Eur Respir J 2003, 22:462-469. 10.1183/09031936.03.00094203, 14516136.
279. Eisner MD, Balmes J, Katz PP, Trupin L, Yelin EH, Blanc PD. Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease. Environ Health 2005, 4:7-14. 10.1186/1476-069X-4-7, 1145187, 15890079.
280. Tsushima K, Sone S, Yoshikawa S, Furuya S, Yasuo M, Suzuki T, Yamazaki Y, Koizumi T, Fujimoto K, Kubo K. Clinical differences in the Global Initiative for Chronic Obstructive Lung Disease Stage 0. Respir Med 2006, 100:1360-1367. 10.1016/j.rmed.2005.11.021, 16403614.
281. Tverdal A, Thelle D, Stensvold I, Leren P, Bjartveit K. Mortality in relation to smoking history: 13 years' follow-up of 68, 000 Norwegian men and women 35-49 years. J Clin Epidemiol 1993, 46:475-487. 10.1016/0895-4356(93)90025-V, 8501474.
282. Urrutia I, Capelastegui A, Quintana JM, Muñiozguren N, Basagana X, Sunyer J. Smoking habit, respiratory symptoms and lung function in young adults. Eur J Public Health 2005, 15:160-165. 10.1093/eurpub/cki113, 15941761.
283. Dahl M, Tybjærg-Hansen A, Vestbo J, Lange P, Nordestgaard BG. Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001, 164:1008-1011.
284. Viegi G, Paoletti P, Prediletto R, Carrozzi L, Fazzi P, Di Pede F, Pistelli G, Giuntini C, Lebowitz MD. Prevalence of respiratory symptoms in an unpolluted area of Northern Italy. Eur Respir J 1988, 1:311-318.
285. Viegi G, Pedreschi M, Pistelli F, Di Pede F, Baldacci S, Carrozzi L, Giuntini C. Prevalence of airways obstruction in a general population: European Respiratory Society vs American Thoracic Society definition. Chest 2000, 117:339S-345S. 10.1378/chest.117.5_suppl_2.339S, 10843974.
286. Vikgren J, Boijsen M, Andelid K, Ekberg-Jansson A, Larsson S, Bake B, Tylén U. High-resolution computed tomography in healthy smokers and never-smokers: a 6-year follow-up study of men born in 1933. Acta Radiol 2004, 45:44-52. 10.1080/02841850310002970, 15164778.
287. Vikgren J, Bake B, Ekberg-Jansson A, Larsson S, Tylén U. Value of air trapping in detection of small airways disease in smokers. Acta Radiol 2003, 44:517-524.
288. Tylén U, Boijsen M, Ekberg-Jansson A, Bake B, Löfdahl CG. Emphysematous lesions and lung function in healthy smokers 60 years of age. Respir Med 2000, 94:38-43. 10.1053/rmed.1999.0690, 10714477.
289. Vineis P, Airoldi L, Veglia F, Olgiati L, Pastorelli R, Autrup H, Dunning A, Garte S, Gormally E, Hainaut P, et al. Environmental tobacco smoke and risk of respiratory cancer and chronic obstructive pulmonary disease in former and never smokers in the EPIC prospective study. BMJ 2005, 330:277-280. 10.1136/bmj.38327.648472.82, 548173, 15681570.
290. Vollmer WM, McCamant LE, Johnson LR, Buist AS. Respiratory symptoms, lung function, and mortality in a screening center cohort. Am J Epidemiol 1989, 129:1157-1169.
291. von Hertzen L, Reunanen A, Impivaara O, Mälkiä E, Aromaa A. Airway obstruction in relation to symptoms in chronic respiratory disease-a nationally representative population study. Respir Med 2000, 94:356-363. 10.1053/rmed.1999.0715, 10845434.
292. Wagena EJ, Kant I, van Amelsvoort LGPM, Wouters EFM, van Schayck CP, Swaen GMH. Risk of depression and anxiety in employees with chronic bronchitis: the modifying effect of cigarette smoking. Psychosom Med 2004, 66:729-734. 10.1097/01.psy.0000138127.00991.cf, 15385698.
293. Kant IJ, Bültmann U, Schröer KAP, Beurskens AJHM, van Amelsvoort LGPM, Swaen GMH. An epidemiological approach to study fatigue in the working population: the Maastricht Cohort Study. Occup Environ Med 2003, 60(Suppl I):i32-i39. 1765733, 12782745.
294. Wagena EJ, van Amelsvoort LGPM, Kant I, Wouters EFM. Chronic bronchitis, cigarette smoking, and the subsequent onset of depression and anxiety: results from a prospective population-based cohort study. Psychosom Med 2005, 67:656-660. 10.1097/01.psy.0000171197.29484.6b, 16046384.
295. Wald NJ, Watt HC. Prospective study of effect of switching from cigarettes to pipes or cigars on mortality from three smoking related diseases. BMJ 1997, 314:1860-1863. 2126967, 9224127.
296. Wang Q, Takashima S, Wang JC, Zheng LM, Sone S. Prevalence of emphysema in individuals who underwent screening CT for lung cancer in Nagano prefecture of Japan. Respiration 2001, 68:352-356. 10.1159/000050526, 11464080.
297. Watson L, Margetts B, Howarth P, Dorward M, Thompson R, Little P. The association between diet and chronic obstructive pulmonary disease in subjects selected from general practice. Eur Respir J 2002, 20:313-318. 10.1183/09031936.02.00256402, 12212961.
298. Weiss W, Boucot KR, Cooper DA, Carnahan WJ. Smoking and the health of older men. II. Smoking and ventilatory function. Arch Environ Health 1963, 7:538-547.
299. Wen C-P, Tsai SPT, Chen C-J, Cheng T-Y. The mortality risks of smokers in Taiwan: Part I: cause-specific mortality. Prev Med 2004, 39:528-535. 10.1016/j.ypmed.2004.02.010, 15313092.
300. Wig KL, Guleria JS, Bhasin RC, Holems E, Vasudeva YL, Singh H. Certain clinical and epidemiological aspects of chronic bronchitis as seen in Northern India. Indian Journal of Chest Diseases 1964, 6:183-194.
301. Wilhelmsen L, Orha I, Tibblin G. Decrease in ventilatory capacity between ages of 50 and 54 in representative samples of Swedish men. Br Med J 1969, 3:553-556. 10.1136/bmj.3.5670.553, 1984332, 5803685.
302. Wilson D, Adams R, Appleton S, Ruffin R. Difficulties identifying and targeting COPD and population-attributable risk of smoking for COPD: a population study. Chest 2005, 128:2035-2042. 10.1378/chest.128.4.2035, 16236852.
303. Wilson DH, Chittleborough CR, Kirke K, Grant JF, Ruffin RE. The health-related quality of life of male and female heavy smokers. Soz Praventivmed 2004, 49:406-412. 10.1007/s00038-004-3075-1, 15669441.
304. Wojtyniak B, Krzyżanowski M, Je{ogonek}drychowski W. Importance of urban air pollution in chronic respiratory problems. Z Erkr Atmungsorgane 1984, 163:274-284.
305. Jedrychowski W. Biological meaning of the prospective epidemiological study on chronic obstructive lung disease and aging. Arch Gerontol Geriatr 1983, 2:237-248. 10.1016/0167-4943(83)90027-4, 6651396.
306. Woods RK, Burton DL, Wharton C, McKenzie GH, Walters EH, Comino EJ, Abramson MJ. Asthma is more prevalent in rural New South Wales than metropolitan Victoria, Australia. Respirology 2000, 5:257-263. 10.1046/j.1440-1843.2000.00257.x, 11022988.
307. Woolf CR. Clinical findings, sputum examinations, and pulmonary function tests related to the smoking habit of 500 women. Chest 1974, 66:652-659. 10.1378/chest.66.6.652, 4426198.
308. Xiao D, Wang C, Du MJ, Pang BS, Zhang HY, Xiao B, Liu JZ, Weng XZ, Su L, Christiani DC. Relationship between polymorphisms of genes encoding microsomal epoxide hydrolase and glutathione S-transferase P1 and chronic obstructive pulmonary disease. Chin Med J 2004, 117:661-667.
309. Xu F, Yin X, Zhang M, Shen H, Lu L, Xu Y. Prevalence of physician-diagnosed COPD and its association with smoking among urban and rural residents in regional mainland China. Chest 2005, 128:2818-2823. 10.1378/chest.128.4.2818, 16236960.
310. Yamaguchi S, Kano K, Shimojo N, Sano K, Xu XP, Watanabe H, Kameyama M, Santamaria MJ, Liu SJ, Wang LH, et al. Risk factors in chronic obstructive pulmonary malfunction and "chronic bronchitis" symptoms in Beijing district: a joint study between Japan and China. J Epidemiol Community Health 1988, 43:1-6.
311. Yuan JM, Ross RK, Wang XL, Gao YT, Henderson BE, Yu MC. Morbidity and mortality in relation to cigarette smoking in Shanghai, China: a prospective male cohort study. JAMA 1996, 275:1646-1650. 10.1001/jama.275.21.1646, 8637137.
312. Zieliñski J, Bednarek M. Early detection of COPD in a high-risk population using spirometric screening. Chest 2001, 119:731-736. 10.1378/chest.119.3.731, 11243950.
313. Górecka D, Bednarek M, Kisło A, Zalewska A, Czechowska U, Je{ogonek}drzejczak M, Zieliński J. Świadomość nieprawidłowego wyniku spirometrii poła{ogonek}czona z porada{ogonek} antynikotynowa{ogonek} zwie{ogonek}ksza szanse{ogonek} zaprzestania palenia (Awareness of airflow obstruction together with antismoking advice increases success in cessation smoking). Pneumonol Alergol Pol 2001, 69:617-625.
314. Bednarek M, Pływaczewski R, Górecka D, Puścińska E, Nowiński A, Zieliński J. Wczesne rozpoznawanie POChP badaniem spirometrycznym u pala{ogonek}cych papierosy mieszkańców Warszawy (Early detection of COPD in smokers from Warsaw using spirometric screening). Pneumonol Alergol Pol 2002, 70:139-147.
315. Zielinski J, Bednarek M, Górecka D. Early detection of COPD by high-risk population screening. Eur Respir J 2006, 27:833-837. 10.1183/09031936.06.00025905, 16585092.
316. Zieliński J, Bednarek M, Górecka D. Naroaowy program wczesnego rozpoznawania i profilaktyki POChP w latach 2000-2002 (National Program of Early Detection and Prevention of COPD in the years 2000-2002). Pneumonol Alergol Pol 2005, 73:116-121.
317. Bednarek M, Zielínski J, Górecka D. Charakterystyka nałogu palenia wśród uczestników narodowego programu wczesnego rozpoznawania i profilaktyki POChP w latach 2000-2002 (Characteristics of smoking habits in participants of the National Program of Early Detection and Prevention of COPD in the years 2000-2002). Pneumonol Alergol Pol 2005, 73:122-127.
318. Zietkowski Z, Kucharewicz I, Bodzenta-Lukaszyk A. The influence of inhaled corticosteroids on exhaled nitric oxide in stable chronic obstructive pulmonary disease. Respir Med 2005, 99:816-824. 10.1016/j.rmed.2004.12.008, 15939243.
319. Zoia MC, Fanfulla F, Bruschi C, Basso O, de Marco R, Casali L, Cerveri I. Chronic respiratory symptoms, bronchial responsiveness and dietary sodium and potassium: a population-based study. Monaldi Arch Chest Dis 1995, 50:104-108.
320. Altman DG, Machin D, Bryant TN, Gardner MJ. Statistics with confidence 2000, London: BMJ Books, 2.
321. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188. 10.1016/0197-2456(86)90046-2, 3802833.
322. SAS Institute Inc The GLM procedure. SAS/STAT user's guide (Online Documentation Version 8) Cary, N.C., SAS Institute Inc., http://www.sfu.ca/sasdoc/sashtml/stat/chap30/index.htm
323. World Health Organisation International classification of diseases. Manual of the international statistical classification of diseases, injuries, and causes of death. Based on the recommendations of the eighth revision conference, 1965, and adopted by the nineteenth world health assembly 1967, 1. Geneva: WHO, World Health Organisation.
324. Office of Population Censuses and Surveys Mortality statistics: cause. Review of the Registrar General on deaths by cause, sex and age, in England and Wales, 1978 1980, London: HMSO, Series DH2 no. 5, Office of Population Censuses and Surveys.